KTVU reports that about 4,300 fewer people get Pfizer vaccine than they should have.
The media said too little was received due to a problem with the new syringe.
California health officials said patients would be informed “immediately” if they needed a booster.
Visit Business Insider’s section for more stories.
Thousands of people who visited a mass vaccination facility in Oakland, Calif. On March 1, received incorrect doses of Pfizer vaccine, according to KTVU.
About 4,300 people were taking less than the recommended dose while filming in the Oakland Coliseum, two unnamed medical staff told the media.
KTVU says the optimal vaccine dose is Pfizer̵7;s 0.3-mL, but thousands of people get about 0.2 mL.
Because of a problem with the syringe, too little was received with the COVID-19 vaccine, media reports.
The mix took place on Monday morning. But it was identified and resolved by 2pm, government officials confirmed to KTVU.
The two agencies that run a number of vaccination sites – the California Emergency Services Agency and the Federal Emergency Management Agency – were not aware of the issue until the KTVU alerted Tuesday.
The State Department of Health, the U.S. Health and Human Services (HHS) and Pfizer held an emergency meeting Tuesday to discuss the bug, a California OES spokesman told media.
Then, officials from the California Department of Health made a careful visit to the Oakland Coliseum. Said a spokesperson.
Ali Bay, deputy director of communications for the health department, told KTVU on Friday that no one who received the March 1 vaccine “was harmed or would have been harmed if we were to conclude that they had received a dose of the vaccine.” That’s a little less. “
Those vaccinated on that date are not advised to see a doctor. But Bay said patients would be informed “immediately” if they needed an emergency pacemaker.
The California Department of Health is currently working with HHS, CDC and Pfizer to “ensure vaccine and quality assurance best practices are followed at this site,” Bay told KTVU.
Read the original article on Business Insider.